Share on StockTwits

Cardinal Health (NYSE:CAH)‘s stock had its “buy” rating restated by equities researchers at Argus in a research report issued on Monday. They currently have a $71.43 target price on the stock, down from their previous target price of $83.00.

In other Cardinal Health news, Insider Craig S. Morford sold 43,359 shares of the company’s stock on the open market in a transaction dated Friday, August 8th. The stock was sold at an average price of $70.03, for a total transaction of $3,036,430.77. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Several other analysts have also recently commented on the stock. Analysts at Barclays reiterated an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $82.00 price target on the stock, up previously from $77.00. Separately, analysts at Credit Suisse reiterated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $80.00 price target on the stock, up previously from $76.00. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $74.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $77.93.

Shares of Cardinal Health (NYSE:CAH) opened at 71.43 on Monday. Cardinal Health has a 52-week low of $49.65 and a 52-week high of $74.40. The stock has a 50-day moving average of $70.89 and a 200-day moving average of $69.49. The company has a market cap of $24.047 billion and a P/E ratio of 21.14.

Cardinal Health (NYSE:CAH) last announced its earnings results on Monday, August 4th. The company reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter in the previous year, the company posted $0.79 earnings per share. The company’s revenue for the quarter was down 9.9% on a year-over-year basis. On average, analysts predict that Cardinal Health will post $4.24 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.3425 per share. This represents a $1.37 dividend on an annualized basis and a yield of 1.92%. The ex-dividend date of this dividend is Monday, September 29th.

Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.